BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Treatment
17 results:

  • 1. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
    Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
    Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
    Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
    Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and
    Pasha A; Kumbhakar DV; Doneti R; Kumar K; Dharmapuri G; Poleboyina PK; S K H; Basavaraju P; Pasumarthi D; S D A; Soujanya P; Arnold Emeson I; Bodiga V; Pawar SC
    Oxid Med Cell Longev; 2021; 2021():6692628. PubMed ID: 33815659
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gynecological Sarcomas: Molecular Characteristics, Behavior, and Histology-Driven Therapy.
    Libertini M; Hallin M; Thway K; Noujaim J; Benson C; van der Graaf W; Jones RL
    Int J Surg Pathol; 2021 Feb; 29(1):4-20. PubMed ID: 32909482
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report.
    Verschoor AJ; Warmerdam FARM; Bosse T; Bovée JVMG; Gelderblom H
    BMC Cancer; 2018 Jan; 18(1):92. PubMed ID: 29357824
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.
    Cuppens T; Moisse M; Depreeuw J; Annibali D; Colas E; Gil-Moreno A; Huvila J; Carpén O; Zikán M; Matias-Guiu X; Moerman P; Croce S; Lambrechts D; Amant F
    Int J Cancer; 2018 Mar; 142(6):1230-1243. PubMed ID: 29063609
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. ywhae Rearrangement in a Purely Conventional Low-grade Endometrial Stromal Sarcoma that Transformed Over Time to High-grade Sarcoma: Importance of Molecular Testing.
    Aisagbonhi O; Harrison B; Zhao L; Osgood R; Chebib I; Oliva E
    Int J Gynecol Pathol; 2018 Sep; 37(5):441-447. PubMed ID: 28863072
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ywhae-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy.
    Hemming ML; Wagner AJ; Nucci MR; Chiang S; Wang L; Hensley ML; George S
    Gynecol Oncol; 2017 Jun; 145(3):531-535. PubMed ID: 28390819
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Laparoscopic Radical Hysterectomy in Early Stage Cervical cancer: A Systematic Review and Meta-Analysis.
    Zhao Y; Hang B; Xiong GW; Zhang XW
    J Laparoendosc Adv Surg Tech A; 2017 Nov; 27(11):1132-1144. PubMed ID: 28300465
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. uterine sarcoma Part II-uterine endometrial stromal sarcoma: The TAG systematic review.
    Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
    Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids.
    Bhave Chittawar P; Franik S; Pouwer AW; Farquhar C
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004638. PubMed ID: 25331441
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and ywhae-FAM22 translocation status as predictors of survival.
    Gremel G; Liew M; Hamzei F; Hardell E; Selling J; Ghaderi M; Stemme S; Pontén F; Carlson JW
    Int J Cancer; 2015 Apr; 136(7):1608-18. PubMed ID: 25130488
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches.
    Philip CA; Pautier P; Duffaud F; Ray-Coquard I
    Curr Oncol Rep; 2014 Oct; 16(10):405. PubMed ID: 25123078
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Second cancers in patients with the Ewing sarcoma family of tumours.
    Navid F; Billups C; Liu T; Krasin MJ; Rodriguez-Galindo C
    Eur J Cancer; 2008 May; 44(7):983-91. PubMed ID: 18353632
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Granulocytic sarcoma: report of three cases.
    Mwanda WO; Rajab JA
    East Afr Med J; 1999 Oct; 76(10):594-6. PubMed ID: 10734514
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A comparison of the evaluation and treatment of cervical dysplasia by gynecologists and nurse practitioners.
    Morris DL; McLean CH; Bishop SL; Harlow KC
    Nurse Pract; 1998 Apr; 23(4):101-2, 108-10, 113-4. PubMed ID: 9579352
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.